EUVIMEDEUVIMED entdecken
Crossref

Potent inhibitors of tumor associated carbonic anhydrases endowed with cathepsin B inhibition

Amit Kumar, Priyanka Arya, Vikas Sharma, Simone Giovannuzzi, Neera Raghav, Claudiu T Supuran, Pawan K Sharma

Archiv der Pharmazie · 2023

DOI: 10.1002/ardp.202300349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2023. Verfasst von Amit Kumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Kurukshetra University, Kurukshetra, India. Hauptthemen laut MEDLINE: Carbonic Anhydrases, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Twenty‐one novel extended analogs of acetazolamide were synthesized and screened in vitro for their inhibition efficacy against human carbonic anhydrase (hCA) isoforms I, II, IX, XII, and cathepsin B. The majority of the compounds were found to be effective inhibitors of tumor‐associated hCA IX and XII, and poor inhibitors of cytosolic hCA I. Despite the strong to moderate inhibition potential possessed by these compounds toward another cytosolic isoform hCA II, some of them demonstrated better potency against hCA IX and/or XII isoforms as compared to hCA II. Four compounds ( 11f , 11g , 12c , and 12g ) effectively inhibited hCA IX and/or XII isoforms with considerable selectivity over the off‐targets hCA I and II. Interestingly, five compounds, including 11f , 11g , 12c , 12d , and 12g , inhibited hCA IX even better than the clinically used acetazolamide. Some of the novel synthesized compounds exhibited higher anti‐cathepsin B potential than acetazolamide, with % inhibition of around 50%, at a concentration of 10 −7 M. Further, two compounds ( 12g and 12c ) that showed effective and selective inhibition activity profiles against hCA IX and XII were additionally found to be effective inhibitors of cathepsin B.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic AnhydrasesNeoplasmsHumansAcetazolamideCathepsin BStructure-Activity RelationshipCarbonic Anhydrase InhibitorsCarbonic Anhydrase IProtein IsoformsMolecular Structure

Stichwörter der Autor:innen

1,3,4-thiadiazolebenzenesulfonamidecarbonic anhydrase inhibitorscathepsin B inhibitorstail approach

Substanzen

Carbonic AnhydrasesAcetazolamideCathepsin BCarbonic Anhydrase InhibitorsCarbonic Anhydrase IProtein Isoforms

Autor:innen und Institutionen

  • Department of Chemistry, Kurukshetra University, Kurukshetra, India.
  • Department of Chemistry, Pt. Chiranji Lal Sharma Government College, Karnal, India.
  • Neurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Florence, Italy.
  • Department of Chemistry, Central University of Haryana, Mahendergarh, India.

Zitieren

APA

Kumar, A., Arya, P., Sharma, V., Giovannuzzi, S., Raghav, N., Supuran, C. T., & Sharma, P. K. (2023). Potent inhibitors of tumor associated carbonic anhydrases endowed with cathepsin B inhibition. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202300349

Vancouver

Kumar A, Arya P, Sharma V, Giovannuzzi S, Raghav N, Supuran CT, et al. Potent inhibitors of tumor associated carbonic anhydrases endowed with cathepsin B inhibition. Archiv der Pharmazie. 2023. doi:10.1002/ardp.202300349

BibTeX
@article{Kumar2023,
  author = {Kumar, Amit and Arya, Priyanka and Sharma, Vikas and Giovannuzzi, Simone and Raghav, Neera and Supuran, Claudiu T and Sharma, Pawan K},
  title = {Potent inhibitors of tumor associated carbonic anhydrases endowed with cathepsin B inhibition},
  journal = {Archiv der Pharmazie},
  year = {2023},
  doi = {10.1002/ardp.202300349}
}
Kostenlos starten →